Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China's Health Card Program Offers Potential For Massive Data Mining

This article was originally published in The Pink Sheet Daily

Executive Summary

Fifty percent of the country's residents are slated to receive electronic medical cards by year's end, establishing a system that could vastly improve personalized care, comparative effectiveness research and adverse event monitoring.

You may also be interested in...



FDA Thinking "Seriously, Deeply" About Range Of Approval Strategies – Hamburg

FDA is considering further “modulations” of its current approaches to drug approvals in order to encourage innovation and get products to market more quickly, Commissioner Margaret Hamburg commented during a panel session at the Biotechnology Industry Organization International Convention in Washington, D.C. on June 28.

Meaningful Electronic Health Records Needed For Comparative Effectiveness

Two areas drawing a lot of attention in the health care reform debate - electronic health records (a major component of the health information technology discussion) and comparative effectiveness - can be more productive in generating useful data if goals for each are developed in concert with one another

Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind

Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS072711

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel